Pfizer Wins Fast Track Designation for Potential NASH Drug Combination
May 26, 2022

Early phase 2a study results of a combination of the 2 agents previously evaluated as NASH monotherapies led to the FDA award for Pfizer.

Risk for HF Hospitalization in Type 2 Diabetes Lower with First-line SGLT-2 Inhibitor vs Metformin
May 26, 2022

Initiating T2D treatment with an SGLT2 inhibitor reduced risk for heart failure hospitalization compared to metformin in a new study; cardiovascular outcomes were similar.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
May 25, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Is There Room for TikTok in Medicine? A Young Clinician Explains
May 25, 2022

Lead author of a recent study discusses why clinicians may be hesitant to use TikTok and how social media may shape health care going forward.

National Kidney Foundation Urges USPSTF to Prioritize Screening Recommendation for CKD
May 25, 2022

The USPSTF is rumored to have moved screening for chronic kidney disease to a preventive service it is actively considering and the NFK says, "It's time."

Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
May 25, 2022

Kosiborod, a cardiologist, and Skolnik, a family practitioner, agree no single specialty owns that prescription and that "it takes a village to care for a patient."

Monkeypox: What We Know About the Outbreak Now
May 24, 2022

The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.

COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
May 24, 2022

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
May 24, 2022

Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.

Metformin, Lifestyle in Prediabetes May Reduce Risk of T2D but Not Major CV Events
May 24, 2022

Among more than 3000 participants with prediabetes, neither metformin or lifestyle change reduced risk for CV events over 21 years according to Diabetes Prevention Program Outcomes Study investigators.